Oct. 19, 2014
October 19, 2014. Check-Cap Ltd., the developer of the world's first preparation-free, non-invasive, high-resolution imaging system for colorectal cancer screening, closed a financing round to support clinical development of the its imaging system. The round was led by Fosun Pharma, a leading healthcare company from China, which was joined by General Electric Ventures, Pontifax, Docor, Counterpoint, MNS and several additional investors.
Following the success of its clinical proof of concept, Check-Cap plans to expand its clinical program by launching a pivotal study in Europe and expects to submit a request for a CE mark toward the end of 2015. A study in the U.S. is planned subsequently. The company also intends to pursue regulatory approvals in China and Japan.